Navigation Links
Bacterin Becomes Premier Founding Sponsor of RMEC's New Osteobiologics Registry

BELGRADE, Mont., Nov. 3, 2011 /PRNewswire/ -- Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, has become a premier founding sponsor of the Resources for Medical Education and Collaboration (RMEC) Osteobiologics Registry with an initial $100,000 unrestricted educational grant.

The goal of the Osteobiologics Registry is to develop a multi-center, longitudinal, observational registry designed to collect data surrounding the application and efficacy of osteobiologics in spinal fusion surgery, along with a mission to educate surgeons on this important topic. This effort aims to improve patient care and outcomes, reduce complications, track cost data, and identify solutions for osteobiologics in spinal procedures.

According to a statement by the RMEC: "Bacterin's support at this nascent stage is indicative of the importance of the mission and the imperative need for broad based support for data collection. Bacterin's support as a premier founding supporter is a testament to their interest in supporting the need to improve available data guiding efficacious use."

Guy Cook, CEO and chairman of Bacterin, commented: "We are excited to see a group of highly respected surgeons committed to improving the understanding of osteobiologics by founding this registry. Bacterin believes there should be better transparency in this space, and even though there are many variables that go into this type of registry, the goals and mission of this collaboration are ideally suited to the needs of the market."

The register's founding group includes five uniquely qualified clinicians and researchers in the areas of osteobiologics and orthopedics:

  • Jeffrey C. Wang, MD, professor of Orthopaedics and Neurosurgery of the UCLA School of Medicine;
  • Howard S. An, MD, The Morton Endowed Chair Professor of Orthopaedic Surgery, Director, Division of Spine Surgery, Rush University Medical Center;
  • Wellington K. Hsu, MD, assistant professor at the Northwestern University Feinberg School of Medicine;
  • Jay R. Lieberman, MD, director of the New England Musculoskeletal Institute, professor and chairman of the department of Orthopaedic Surgery at the University of Connecticut; and
  • S. Tim Yoon, MD, associate professor of orthopedic surgery at Emory University.

About RMEC

Resources for Medical Education and Collaboration (RMEC), a Colorado based 501c3, provides administrative resources to enable the development, growth, and support for the Osteobiologics Collaborative, including promoting partnerships, fundraising, and meeting organization.

RMEC was founded in 2008 and strives to improve health care quality and delivery through collaborative research and education, locally and globally through hosting medical education conferences (Evidence and Technology Spine Summit, The Osteobiologics Meeting), providing local internship opportunities, supporting research activities in clinical medicine, and bringing clinical health care and on-site medical education to developing regions of the world. In addition to founder Jim A. Youssef, MD, of Spine Colorado, RMEC's board of directors includes Darrel Brodke, MD, of the University of Utah Orthopedic Center and Paul Gervais, CPA of Durango, Colorado. Caitlyn McCullough serves as RMEC's executive director. Visit for more information.

About Bacterin International Holdings

Bacterin International Holdings, Inc. (NYSE Amex: BONE) develops, manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair and dermal growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.

Bacterin's Medical Device division develops, employs, and licenses bioactive coatings for various medical device applications. Bacterin's strategic coating initiatives include antimicrobial coatings designed to inhibit biofilm formation and microbial contamination. For further information, please visit

Investor Relations:
Liolios Group, Inc.
Scott Liolios or Ron Both
Tel 949-574-3860

SOURCE Bacterin International Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Bacterin to Present at Lazard Capital Markets 8th Annual Healthcare Conference on November 16, 2011
2. Bacterin Sponsors the 2012 Donate Life Rose Parade Float in Recognition of Donor Families
3. Bacterin International to Present at Stifel Nicolaus 2011 Healthcare Conference on September 8, 2011
4. Bacterin Reports New Hires and Management Reorganization, Driving Most Active Processing Month in July
5. Bacterin International Signs Its Second National GPO Contract for Bacterin Biologics and Its First For Wound Drains with ROi
6. Bacterin International to Present at Noble Financial Capital Markets Seventh Annual Equity Conference on May 16, 2011
7. Bacterin International Secures $1.9 million in Private Placement
8. Bacterin International Updates Fourth Quarter and Full Year 2010 Financial Results
9. Bacterin International Signs LOI to Acquire Assets of Robinson MedSurg LLC
10. Bacterin International Holdings Secures $5,000,000 Credit Facility with Bridge Bank
11. Bacterin International Reconstitutes Its Board of Directors and Appoints Experienced Legal and Financial Professionals
Post Your Comments:
(Date:12/1/2015)... Texas (PRWEB) , ... December ... ... , a leading relationship marketing company specializing in scientifically backed, age-defying products, ... January 2016 issue, which highlights the exponential success and unrivaled opportunities that ...
(Date:12/1/2015)... ... December 01, 2015 , ... The ... and Dr. J. Kyle Mathews will join fellow surgeons in the ... site hysterectomy. , An experienced urogynecologist, founder of Plano Urogynecology Associates and ...
(Date:11/30/2015)... MIAMI (PRWEB) , ... November 30, 2015 , ... ... design and development stages of a new closed system for isolating adipose-derived stem cells. ... stromal vascular fraction (SVF) of adipose tissue. SVF is a component of the lipoaspirate ...
(Date:11/30/2015)... (NYSE: BIOA ), a leader in renewable materials, today ... Climate Pledge, alongside more than 140 companies from across the ... demonstrate an ongoing commitment to climate action and to voice ... Paris climate negotiations. Sarnia, Canada ... --> BioAmber uses biotechnology to convert renewable sugars ...
Breaking Biology Technology:
(Date:11/19/2015)... Nov. 19, 2015  Although some 350 companies are ... by a few companies, according to Kalorama Information. These include ... of the market share of the 6.1 billion-dollar molecular ... World Market for Molecular Diagnostic s .    ... is still controlled by one company and only a ...
(Date:11/17/2015)... Calif. , Nov. 17, 2015  Vigilant Solutions ... has joined its Board of Directors. ... Board after recently retiring from the partnership at TPG ... 107 companies with over $140 Billion in revenue.  He ... improvement across all the TPG companies, from 1997 to ...
(Date:11/12/2015)... --  Growing need for low-cost, easy to use, ... the way for use of biochemical sensors for ... clinical, agricultural, environmental, food and defense applications. Presently, ... applications, however, their adoption is increasing in agricultural, ... on improving product quality and growing need to ...
Breaking Biology News(10 mins):